Navigation Links
Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
Date:10/27/2011

uch as decreased hemoglobin, fatigue, and osteoporosis.

About Regeneron PharmaceuticalsRegeneron is a fully integrated biopharmaceutical company that discovers, develops, manufacturers, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, which is approved for the treatment of a rare inflammatory condition, Regeneron has completed Phase 3 clinical trials of rilonacept for a new indication and of product candidates EYLEA™ (aflibercept injection; VEGF Trap-Eye) in diseases of the eye, and ZALTRAP® (aflibercept;VEGF Trap) in colorectal cancer.  EYLEA is currently under review with U.S. and European regulatory authorities.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on www.regeneron.com

Forward Looking StatementsThis news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future financial performance of Regeneron, and actual events or results may differ materially from these forward-looking statements.  These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications of Regeneron's product candidates and research and clinical programs now underway or planned, the likelihood and timing of possible regulatory approval and commercial launch of Regeneron's late-stage product candidates, determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to devel
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
2. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
3. Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index™
4. Hepatitis C Phase 2A Trial Positive Results
5. Daval International Announces Positive Phase II Results for AIMSPRO® as a Monotherapy in Established Diffuse Cutaneous Systemic Sclerosis (Scleroderma)
6. Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony® Continuous Glucose Monitoring System
7. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
8. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
9. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
10. ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer
11. Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Tobramycin ... Tobramycin is a traditional antibiotic whose eye drop and ... treatment of potential infection or inflammation caused by eye ... are able to produce tobramycin, among which ...
(Date:8/28/2015)... , Aug. 28, 2015 Patterson Medical, ... (Nasdaq: PDCO ), is now an independent ... acquisition of Patterson Medical by Madison Dearborn Partners ... its name for a transition period before rebranding ... and sports medicine products.  With the focused resources ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... to their offering. Developed by Novo ... Novolog) is an important drug for the treatment ... as a fast- acting insulin analog, starts working ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... , MT. LAUREL, N.J., Dec. 1 ... of technology-enabled clinical documentation services, today announced that the radiology ... SpeechQ for Radiology(TM), MedQuist,s real-time speech recognition system. The solution ... (RSNA) convention November 29 through December 2. ...
... , PISCATAWAY, N.J., Dec. 1 Siemens ... hearing instruments, announced its third annual partnership with Quota International,s ... 2010. , As part of the renewed partnership, Siemens is ... instruments to both children and young adults, age 23 years ...
Cached Medicine Technology:MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3
(Date:8/28/2015)... ... 28, 2015 , ... “ Frequentz ” was featured on NewsWatch as part ... on the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch ... allows businesses to track product movement from beginning to end. , Businesses benefit greatly ...
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest travel ... in Healthcare by Modern Healthcare and will be honored at an awards dinner ... year, the Best Places to Work in Healthcare program recognizes outstanding employers in the ...
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., ... pain resulting in shoulder pain, hip pain, neck pain, stiffness, muscle spasms, ... from the University of Illinois, and then went on to earn his title of ...
(Date:8/28/2015)... ... ... Northridge dentists Dr. Elyson and Dr. Assili are now offering ... receive a one hour treatment of this teeth whitening option. Zoom whitening ... unique features that can turn teeth up to nine shades whiter. Effective on a ...
(Date:8/28/2015)... Ca (PRWEB) , ... August 28, 2015 , ... ... administering medical evaluations for those seeking to go deep sea diving. The ... oxygen toxicity, and decompression sickness; for these reasons, it is vital that all ...
Breaking Medicine News(10 mins):Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Healthpointe Now Offering Scuba Physicals 2
... ,A new study hints at one reason that black Americans are ... Blacks appear to have higher levels of a certain type of ... standard screening. This so-called "non-calcified plaque" -- which consists of ... can rupture and send out blood clots that can lead to ...
... nurses doubt that a clinical neurological examination can establish that ... that this uncertainty can affect relatives when the question of ... the Sahlgrenska Academy, University of Gothenburg, Sweden. End-of-life ... for patients who are brain dead and who by their ...
... weigh less than their non-consuming counterparts, according to a new ... a peer-reviewed journal. This is potentially important ... But lead researcher Carol O,Neil, PhD, MPH, LDN, RD, Louisiana ... put into perspective. "The study illustrates that children ...
... The process of cell division is tightly regulated, as mistakes ... fingered as causing tumors in both skin and liver. ... Medicine, Vienna, has now uncovered a surprising detail with the ... an important anti-tumor factor. The results have recently been ...
... , TUESDAY, June 28 (HealthDay News) -- A flexible work ... their jobs after giving birth, according to a new study. ... flexible schedule provides working moms with alternatives for meeting those ... better able to control their work environment and adapt, work-related ...
... may have discovered one reason that African Americans are at ... According to a new study published online in the ... non-calcified plaque, which consists of buildups of soft deposits deep ... by some cardiac tests. Non-calcified plaque is more vulnerable to ...
Cached Medicine News:Health News:Study Hints at Why Heart Disease Is More Deadly for Blacks 2Health News:Intensive care nurses have doubts about method for establishing brain death 2Health News:Intensive care nurses have doubts about method for establishing brain death 3Health News:New study shows children and adolescents who eat candy are less overweight or obese 2Health News:The good, the bad and the ugly: The many roles of c-JUN in cancer 2Health News:Flexible Schedule Helps Keep New Moms in the Workplace 2Health News:CT angiography improves detection of heart disease in African-Americans 2
Welch Allyn introduced halogen HPX lamp technology to provide 30% more light output than previous halogen lamps. The mix of halogen and xenon gases provide whiter, longer lasting light - making your ...
RT-600 Refractor...
... Ultramatic Rx Master is designed ... of reliable service and give ... measurably improve procedures. It embodies ... and want most, including accuracy, ...
Occluder and Maddox Rod...
Medicine Products: